Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Mrs T-S M Willson 11/10/2025 Dr R Willson 11/10/2025 25/06/2009 24 June 2026 The principle activity of the company in the year under review was that of contract research into oral healthcare. 06944501 2025-03-31 06944501 bus:Director1 2025-03-31 06944501 bus:Director2 2025-03-31 06944501 2024-03-31 06944501 core:CurrentFinancialInstruments 2025-03-31 06944501 core:CurrentFinancialInstruments 2024-03-31 06944501 core:ShareCapital 2025-03-31 06944501 core:ShareCapital 2024-03-31 06944501 core:RetainedEarningsAccumulatedLosses 2025-03-31 06944501 core:RetainedEarningsAccumulatedLosses 2024-03-31 06944501 core:LeaseholdImprovements 2024-03-31 06944501 core:ToolsEquipment 2024-03-31 06944501 core:ComputerEquipment 2024-03-31 06944501 core:LeaseholdImprovements 2025-03-31 06944501 core:ToolsEquipment 2025-03-31 06944501 core:ComputerEquipment 2025-03-31 06944501 core:CostValuation 2024-03-31 06944501 core:FurtherSpecificIncreaseDecreaseInInvestments1ComponentTotalChangeInInvestments 2025-03-31 06944501 core:CostValuation 2025-03-31 06944501 2024-04-01 2025-03-31 06944501 bus:FilletedAccounts 2024-04-01 2025-03-31 06944501 bus:SmallEntities 2024-04-01 2025-03-31 06944501 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 06944501 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 06944501 bus:Director1 2024-04-01 2025-03-31 06944501 bus:Director2 2024-04-01 2025-03-31 06944501 core:LeaseholdImprovements core:TopRangeValue 2024-04-01 2025-03-31 06944501 core:ToolsEquipment 2024-04-01 2025-03-31 06944501 core:ComputerEquipment core:TopRangeValue 2024-04-01 2025-03-31 06944501 2023-04-01 2024-03-31 06944501 core:LeaseholdImprovements 2024-04-01 2025-03-31 06944501 core:ComputerEquipment 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 06944501 (England and Wales)

# MODUS LABORATORIES LIMITED

### UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH THE REGISTRAR

MODUS LABORATORIES LIMITED

## UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025

Contents

MODUS LABORATORIES LIMITED

## COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
MODUS LABORATORIES LIMITED

## COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025

DIRECTORS | Mrs T-S M Willson (Appointed 11 October 2025)
| Dr R Willson (Resigned 11 October 2025)

SECRETARY | Mrs T-S M Willson

REGISTERED OFFICE | Wey Court West
| Union Road
| Farnham
| Surrey
| GU9 7PT
| United Kingdom

COMPANY NUMBER | 06944501 (England and Wales)

ACCOUNTANT | Shaw Gibbs Limited
| Wey Court West
| Union Road
| Farnham
| Surrey
| GU9 7PT

MODUS LABORATORIES LIMITED

## BALANCE SHEET

AS AT 31 MARCH 2025
MODUS LABORATORIES LIMITED

## BALANCE SHEET (continued)

AS AT 31 MARCH 2025

| Note | 2025 |  | 2024
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 3 | 23,708 |  | 31,610
Investments | 4 | 9,386 |  | 10,969
|  | 33,094 |  | 42,579
Current assets |  |  |  |
Stocks |  | 0 |  | 5,000
Debtors | 5 | 1,500 |  | 127,966
Cash at bank and in hand |  | 552,794 |  | 523,039
|  | 554,294 |  | 656,005
Creditors: amounts falling due within one year | 6 | ( 44,045) |  | ( 63,512)
Net current assets |  | 510,249 |  | 592,493
Total assets less current liabilities |  | 543,343 |  | 635,072
Provision for liabilities |  | ( 5,928) |  | ( 7,903)
Net assets |  | 537,415 |  | 627,169
Capital and reserves |  |  |  |
Called-up share capital |  | 1,000 |  | 1,000
Profit and loss account |  | 536,415 |  | 626,169
Total shareholders' funds |  | 537,415 |  | 627,169

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Modus Laboratories Limited (registered number: 06944501) were approved and authorised for issue by the Director on 24 June 2026. They were signed on its behalf by:

Mrs T-S M Willson Director |

MODUS LABORATORIES LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025
MODUS LABORATORIES LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2025

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

##### General information and basis of accounting

Modus Laboratories Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Wey Court West, Union Road, Farnham, Surrey, GU9 7PT, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Turnover

Turnover represents net invoiced sales of services excluding value added tax. Turnover is recognised when the company obtains the right to consideration.

##### Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

##### Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Leasehold improvements | 3 years straight line
| depreciated over the life of the lease
Tools and equipment | 25 % reducing balance
Computer equipment | 3 years straight line

##### Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow-moving items.

##### Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

##### Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

##### Pension costs and other post-retirement benefits

The company operates a defined contribution scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

#### 2. Employees

| 2025 |  | 2024
| Number |  | Number
Monthly average number of persons employed by the Company during the year, including the director | 2 |  | 2

#### 3. Tangible assets

| Leasehold improve- ments |  | Tools and equipment |  | Computer equipment |  | Total
| £ |  | £ |  | £ |  | £
Cost |  |  |  |  |  |  |
At 01 April 2024 | 30,450 |  | 200,277 |  | 28,592 |  | 259,319
At 31 March 2025 | 30,450 |  | 200,278 |  | 28,592 |  | 259,320
Accumulated depreciation |  |  |  |  |  |  |
At 01 April 2024 | 30,450 |  | 168,667 |  | 28,592 |  | 227,709
Charge for the financial year | 0 |  | 7,903 |  | 0 |  | 7,903
At 31 March 2025 | 30,450 |  | 176,570 |  | 28,592 |  | 235,612
Net book value |  |  |  |  |  |  |
At 31 March 2025 | 0 |  | 23,708 |  | 0 |  | 23,708
At 31 March 2024 | 0 |  | 31,610 |  | 0 |  | 31,610

#### 4. Fixed asset investments

| Listed investments |  | Total
| £ |  | £
Cost or valuation before impairment |  |  |
At 01 April 2024 | 10,969 |  | 10,969
Change in value of loans receivable | ( 1,583) |  | ( 1,583)
At 31 March 2025 | 9,386 |  | 9,386
Carrying value at 31 March 2025 | 9,386 |  | 9,386
Carrying value at 31 March 2024 | 10,969 |  | 10,969

The fair value of listed investments was determined with reference to the quoted market price at the reporting date.

#### 5. Debtors

| 2025 |  | 2024
| £ |  | £
Trade debtors | 0 |  | 122,580
Prepayments | 0 |  | 715
Corporation tax | 0 |  | 2,049
Other debtors | 1,500 |  | 2,622
| 1,500 |  | 127,966

#### 6. Creditors: amounts falling due within one year

| 2025 |  | 2024
| £ |  | £
Amounts owed to director | 149 |  | 36,290
Accruals | 2,800 |  | 2,800
Taxation and social security | 31,767 |  | 18,359
Other creditors | 9,329 |  | 6,063
| 44,045 |  | 63,512

#### 7. Financial commitments

Other financial commitments

| 2025 |  | 2024
| £ |  | £
Minimum lease payments under non-cancellable operating leases - within one year | 17,707 |  | 17,024
Minimum lease payments under non-cancellable operating leases - between one and five years | 10,568 |  | 28,275
| 28,275 |  | 45,299